Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

DepoTech and Chiron submit NDA for DepoCyt

Oct. 13, 1998

Matrix reports promising phase III results for IntraDose in breast cancer

Oct. 13, 1998

NCIC-CTG leads major international trial for new ovarian cancer compound

Oct. 13, 1998

Promising preclinical findings reported for PI-88; phase I testing begins next month

Oct. 13, 1998

Gene therapy targeting Tie2 receptor tyrosine kinase evaluated as antiangiogenic strategy

Oct. 13, 1998

Inex demonstrates effectiveness of new antisense drug

Oct. 13, 1998

New Zeneca facility to manufacture new cancer treatment

Oct. 9, 1998

Pivotal trial of exisulind for prostate cancer recurrence fully enrolled

Oct. 8, 1998

New orally active antitumor platinum complexes synthesized at SS Pharm.

Oct. 8, 1998

Orphan Medical's Busulfex Injection granted priority review

Oct. 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
BIO 2026: Alternatives to funding orphan drugs
BioWorld
At the BIO International Convention, nonprofit and for-profit companies discussed ways to fund orphan drug development, especially for ultra-rare diseases where...
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...